$.' ���� JFIF ` ` �� C q�q>�$�9`�J��ȅ��{�sv?�,?�����#j"*�����;iuc��s��Bn���r��f ��T��*O�l��U�zy�g�Xme�L��v �]�������V��������1�QU~�px[��Z C�W����pp+y��q�C���>>U9m�;-J;�eoà@Ǻ�fUU(�8��.�)�6��cm�E�49. <> 25 November 2020, AUCKLAND, NZ: Listed primary healthcare provider Green Cross Health, the group behind Unichem and Life Pharmacy, The Doctors and Access Community Health, reported revenue of $277m for the six months to 30 September 2020, consistent with the prior period. ",#(7),01444'9=82. endobj See note 2 (c) of the 2019 financial statements. %PDF-1.7 Net Profit After Tax attributable to Shareholders of $8.8 million includes growth in the Medical and Community Health divisions, offsetting weakness in the Pharmacy division. endobj <> Net income decreased 16% to NZ$13.5M. Net income was … 6 0 obj Green Cross developed "Hepavax B", the world's third hepatitis B vaccine, in 1983, the world's first vaccine “Hantavax” against epidemic hemorrhagic fever in 1988, the world's second varicella vaccine in 1995, "Greengene", the world's 4th recombinant antihemophilic drug, and the world's second treatment of Hunter syndrome “Hunterase” in 2012. endstream (�R`�jbk�b^�fIV��4+Ʌ����ڀϢl ni4;�U���d�o�v���)��b�k�q$�ݴ?/�`��}��~/���U�v�(*N�Ej�� Green Cross Health appoints Rachael Newfield as G; Pharmacy and Medical Division CEO Resignation; 2018 Annual Shareholder Meeting Speeches and Prese; F18 GXH Annual Report; Full Year Result Announcement to 31 March 2018; Notice of Annual Meeting and Director Nominations ; Appendix to Full Year Result Announcement to 31 Ma ; Alison Van Wyk appointed as CEO, Community Health ; Simon … <>/XObject<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 960 540] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> (~R���#�V�!9 �������0x�g'�E'���ιkM�Myz6�S`|,Q3)ȃO�D3���n'��!w~!�R�ȭ��h�`p}�.��(��Qҵ%u�~mq �U�M�mҞt׻$o��|��Ҋ˦ /�Vimm۸�)"����}��(7�m���E��7��u��BC/��� �ÓZ�K��%�ʧ� 4 0 obj stream 5 0 obj <> 1 0 obj stream endobj 3 0 obj e^D�������Y>���E�X��� <>/Metadata 1576 0 R/ViewerPreferences 1577 0 R>> ϳ�׈��t�0)���$N���[� �C�g�7�>�%@��V�#=���&��l Find out the revenue, expenses and profit or loss over the last fiscal year. Revenues reflect Medical Services segment increase of 8% to NZ$76.5M, also reflect Pharmacy Retail segment decrease of 1% to NZ$336.4M, Community Care Services segment decrease of 1% to NZ$155.6M. Green Cross Health, the group behind Unichem and Life Pharmacy, The Doctors and Access Community Health, reported revenue of $277m for the six months to 30 September 2020, consistent with the prior period. x��V�n�0}7��\������@zYסٺ&�{�4+к[�n�ߏR����+�ǽ2IS��;����fx=�����3�!PJ� XF�����Ty�9�O�a�,, FINANCIAL BRIEF:: For the fiscal year ended 31 March 2020, Green Cross Health Ltd revenues increased less than 1% to NZ$568.5M. �eAʽ��t�T�(�Ξ+\"/��2I���h��Ѡ�N��t�#��ܭ�I�VÙ}o�vQM��s�z4d�O�����ӿ�n�|݆;���jX(uSz=�@`�o~�|�O� 08| GREEN CROSS HEALTH Result summary • Revenue of $567m (+5.6%) • EBITDA at $36.9m (+2.3%) • Operating Profit $29.4m (-2.2%) • Net Profit after Tax Attributable to the Parent Shareholders of $16.1m (+3.2%) • Pharmacy Revenue flat at $340m, Operating Profit down 5.5% at $27.3m <> endobj %���� GREEN CROSS HEALTH REPORTS HALF YEAR PROFIT OF $8.8M 25 November 2020, AUCKLAND, NZ : Listed primary healthcare provider Green Cross Health, the group behind Unichem and Life Pharmacy, The Doctors and Access Community Health, reported revenue of $277m for the six months to 30 September 2020, consistent with the prior period. Revenue $567.2m +5.6% Pharmacy Same Store Sales +1.1% EBITDA $36.9m +2.3% Medical Same Centre Revenue +4.9% Net Profit After Tax $16.1m (attributable to shareholders) +3.2%1 Consistent Final Dividend 3.5 cps Note: 1 2018 restated to incorporate changes in Accounting Standards and restatement of alternate leave liability. endobj Get the detailed quarterly/annual income statement for Green Cross Health Limited Ordi (GXH.NZ). 2 0 obj